Academic Journal
OP 2.3 – 00117 The EZH2 inhibitor Tazemetostat increases MHC I antigen presentation in vitro and in vivo, enhancing antiviral activities of HIV-specific CTLs
Title: | OP 2.3 – 00117 The EZH2 inhibitor Tazemetostat increases MHC I antigen presentation in vitro and in vivo, enhancing antiviral activities of HIV-specific CTLs |
---|---|
Authors: | A. Gramatica, A. Danesh, I. Miller, J. Weiler, F. Khan, D. Copertino, U. Chukwukere, L. Leyre, B. Jones |
Source: | Journal of Virus Eradication, Vol 8, Iss , Pp 100151- (2022) |
Publisher Information: | Elsevier, 2022. |
Publication Year: | 2022 |
Collection: | LCC:Microbiology LCC:Public aspects of medicine |
Subject Terms: | Microbiology, QR1-502, Public aspects of medicine, RA1-1270 |
Document Type: | article |
File Description: | electronic resource |
Language: | English |
ISSN: | 2055-6640 |
Relation: | http://www.sciencedirect.com/science/article/pii/S2055664022000899; https://doaj.org/toc/2055-6640 |
DOI: | 10.1016/j.jve.2022.100151 |
Access URL: | https://doaj.org/article/b25e1e0441f848138a50f0fb3aa62122 |
Accession Number: | edsdoj.b25e1e0441f848138a50f0fb3aa62122 |
Database: | Directory of Open Access Journals |
ISSN: | 20556640 |
---|---|
DOI: | 10.1016/j.jve.2022.100151 |
Published in: | Journal of Virus Eradication |
Language: | English |